Janux Therapeutics (JANX) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free JANX Stock Alerts $47.10 -1.11 (-2.30%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCerity Partners LLC Makes New $654,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)marketbeat.com - April 24 at 4:43 AMJanux Therapeutics (NASDAQ:JANX) Shares Down 4.1% marketbeat.com - April 17 at 2:37 PMTake the Money and Run: 3 Overbought Stocks to Sell ASAPinvestorplace.com - April 17 at 1:12 PMValidea Detailed Fundamental Analysis - JANXnasdaq.com - April 17 at 7:35 AMJanux Therapeutics (NASDAQ:JANX) Now Covered by Analysts at Jonestradingamericanbankingnews.com - April 17 at 3:48 AMJonesTrading Initiates Coverage of Janux Therapeutics (JANX) with Buy Recommendationmsn.com - April 16 at 11:00 PMJanux a new buy at Jones on lead assets for solid tumorsmsn.com - April 16 at 6:00 PMThese 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?investorplace.com - April 16 at 1:19 PMA Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analystsbenzinga.com - April 16 at 1:00 PMJanux Therapeutics (NASDAQ:JANX) Shares Gap Down to $52.65marketbeat.com - April 15 at 12:53 PMJanux Therapeutics, Inc. (NASDAQ:JANX) Given Average Recommendation of "Buy" by Brokeragesamericanbankingnews.com - April 15 at 4:10 AMWhy Janux Therapeutics Stock Is Crushing It This Weekfool.com - April 12 at 5:40 AMStocks See Continued Pressure as Bond Yields Climbtheglobeandmail.com - April 11 at 12:58 PMWhy Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?benzinga.com - April 11 at 12:58 PMBiotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Optionsfinance.yahoo.com - April 11 at 12:58 PMBiotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Optionsinvestors.com - April 11 at 9:17 AMWhy Janux Therapeutics Stock Soared as the Market Sagged Todayfool.com - April 10 at 6:39 PMJanux Therapeutics (NASDAQ:JANX) Sees Unusually-High Trading Volumemarketbeat.com - April 10 at 3:46 PMJanux Therapeutics surges amid report of takeover interestmsn.com - April 10 at 3:45 PMmarketbeat.com - April 10 at 1:43 PMJanux Therapeutics (NASDAQ:JANX) Stock Price Up 6.9%marketbeat.com - April 8 at 1:45 PMCommit To Purchase Janux Therapeutics At $25, Earn 26.5% Annualized Using Optionsnasdaq.com - April 5 at 5:31 AMJanux Therapeutics Inc Ordinary Shares JANXmorningstar.com - April 5 at 5:31 AMJanux Therapeutics (NASDAQ:JANX) Shares Down 6.7% marketbeat.com - April 2 at 4:18 PMJanux Therapeutics (NASDAQ:JANX) Trading Down 3.3%marketbeat.com - March 27 at 1:42 PMJanux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of "Buy" by Analystsmarketbeat.com - March 21 at 9:12 AMBTIG Research Begins Coverage on Janux Therapeutics (NASDAQ:JANX)marketbeat.com - March 21 at 8:21 AMCantor starts Janux at overweight, cites TCE leadership positionmsn.com - March 20 at 5:03 PMForecasting The Future: 4 Analyst Projections For Janux Therapeuticsmarkets.businessinsider.com - March 20 at 5:03 PMCancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analystfinance.yahoo.com - March 20 at 5:03 PMCancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst - Janux Therapeutics (NASDAQ:JANX)benzinga.com - March 20 at 1:44 PMJanux Therapeutics (NASDAQ:JANX) Research Coverage Started at Cantor Fitzgeraldmarketbeat.com - March 20 at 7:21 AMJanux Therapeutics (NASDAQ:JANX) Shares Gap Down to $38.81marketbeat.com - March 19 at 11:53 AMJANX Stock Earnings: Janux Therapeutics Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 15 at 12:03 PM2 Stocks That Have More Than Tripled This Year: Are They Buys?fool.com - March 15 at 9:45 AMStranahan Recommends Buy on Janux Therapeutics with Increased Price Objective Amid Promising Drug Advancesmarkets.businessinsider.com - March 14 at 10:31 PMB of A Securities Maintains Buy Rating for Janux Therapeutics: Here's What You Need To Knowmarkets.businessinsider.com - March 13 at 3:44 PMEquities Analysts Issue Forecasts for Janux Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:JANX)marketbeat.com - March 13 at 6:50 AMJanux Therapeutics' (JANX) "Outperform" Rating Reiterated at Wedbushmarketbeat.com - March 11 at 6:42 PMJanux Therapeutics (JANX) to Release Earnings on Sundaymarketbeat.com - March 9 at 7:22 AMJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Adage Capital Partners GP L.L.C.marketbeat.com - March 9 at 6:35 AMJanux Therapeutics GAAP EPS of -$0.25 beats by $0.16, revenue of $2.46M beats by $1.72Mmsn.com - March 8 at 7:59 PMJanux Therapeutics Inc (JANX) Reports Encouraging Clinical Data and Solid Financial Position ...finance.yahoo.com - March 8 at 7:59 PMJanux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlightsbusinesswire.com - March 8 at 4:01 PMAfter Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?fool.com - March 2 at 6:56 AMQ1 2024 Earnings Estimate for Janux Therapeutics, Inc. Issued By Wedbush (NASDAQ:JANX)marketbeat.com - March 2 at 2:28 AMBarclays PLC Has $181,000 Position in Janux Therapeutics, Inc. (NASDAQ:JANX)marketbeat.com - March 1 at 4:04 AMJanux Therapeutics prices stock and warrants offering to raise $296.5Mmsn.com - February 29 at 4:21 PMBrokers Set Expectations for Janux Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:JANX)marketbeat.com - February 29 at 9:45 AMFmr LLC Purchases 1,288,526 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)marketbeat.com - February 29 at 5:36 AM Get Janux Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter. Email Address The World's First "$20 Trillion Drug?" (Ad)One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%! Get the name of the stock here >>> JANX Media Mentions By Week JANX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JANX News Sentiment▼1.720.41▲Average Medical News Sentiment JANX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JANX Articles This Week▼12▲JANX Articles Average Week Get Janux Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INDV News Today MOR News Today EVO News Today SMMT News Today MLTX News Today CORT News Today ACAD News Today MRUS News Today VERA News Today RYTM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JANX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Janux Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
